Fig. 9From: Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinomaThe enrichment of the IRLPs subgroups and different expression gene set between IRLPs subgroups a KEGG analysis of high-risk IRLPs subgroup, b KEGG analysis of low-risk IRLPs subgroup, c GO-BP analysis of different expression gene set between IRLPs subgroups, d GO-CC analysis of different expression gene set between IRLPs subgroups, e GO-MF analysis of different expression gene set between IRLPs subgroups, f KEGG analysis of different expression gene set between IRLPs subgroupsBack to article page